vs
Side-by-side financial comparison of TSS, Inc. (TSSI) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $60.9M, roughly 1.3× TSS, Inc.). TSS, Inc. runs the higher net margin — 20.0% vs 7.4%, a 12.6% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 21.8%). TSS, Inc. produced more free cash flow last quarter ($15.8M vs $9.7M). Over the past eight quarters, TSS, Inc.'s revenue compounded faster (95.8% CAGR vs 22.7%).
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
TSSI vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $60.9M | $76.2M |
| Net Profit | $12.2M | $5.6M |
| Gross Margin | 17.6% | 57.9% |
| Operating Margin | 1.5% | 11.0% |
| Net Margin | 20.0% | 7.4% |
| Revenue YoY | 21.8% | 25.5% |
| Net Profit YoY | 535.7% | 30.7% |
| EPS (diluted) | $0.44 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $60.9M | $76.2M | ||
| Q3 25 | $41.9M | $71.9M | ||
| Q2 25 | $44.0M | $63.1M | ||
| Q1 25 | $99.0M | $59.1M | ||
| Q4 24 | $50.0M | $60.7M | ||
| Q3 24 | $70.1M | $58.0M | ||
| Q2 24 | $12.2M | $55.0M | ||
| Q1 24 | $15.9M | $50.6M |
| Q4 25 | $12.2M | $5.6M | ||
| Q3 25 | $-1.5M | $3.5M | ||
| Q2 25 | $1.5M | $3.2M | ||
| Q1 25 | $3.0M | $2.6M | ||
| Q4 24 | $1.9M | $4.3M | ||
| Q3 24 | $2.6M | $3.9M | ||
| Q2 24 | $1.4M | $1.5M | ||
| Q1 24 | $15.0K | $1.6M |
| Q4 25 | 17.6% | 57.9% | ||
| Q3 25 | 11.1% | 57.5% | ||
| Q2 25 | 17.8% | 58.3% | ||
| Q1 25 | 9.3% | 56.3% | ||
| Q4 24 | 14.4% | 59.5% | ||
| Q3 24 | 11.3% | 59.3% | ||
| Q2 24 | 37.3% | 59.8% | ||
| Q1 24 | 17.1% | 58.9% |
| Q4 25 | 1.5% | 11.0% | ||
| Q3 25 | -2.2% | 7.8% | ||
| Q2 25 | 5.1% | 8.1% | ||
| Q1 25 | 4.2% | 6.5% | ||
| Q4 24 | 0.0% | 10.6% | ||
| Q3 24 | 5.4% | 9.7% | ||
| Q2 24 | 14.0% | 6.6% | ||
| Q1 24 | 1.6% | 4.4% |
| Q4 25 | 20.0% | 7.4% | ||
| Q3 25 | -3.6% | 4.9% | ||
| Q2 25 | 3.4% | 5.0% | ||
| Q1 25 | 3.0% | 4.4% | ||
| Q4 24 | 3.8% | 7.1% | ||
| Q3 24 | 3.8% | 6.7% | ||
| Q2 24 | 11.5% | 2.7% | ||
| Q1 24 | 0.1% | 3.2% |
| Q4 25 | $0.44 | $0.14 | ||
| Q3 25 | $-0.06 | $0.09 | ||
| Q2 25 | $0.06 | $0.08 | ||
| Q1 25 | $0.12 | $0.06 | ||
| Q4 24 | $0.08 | $0.10 | ||
| Q3 24 | $0.10 | $0.10 | ||
| Q2 24 | $0.06 | $0.04 | ||
| Q1 24 | $0.00 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $85.5M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $76.6M | $141.5M |
| Total Assets | $184.9M | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $85.5M | $13.5M | ||
| Q3 25 | $70.7M | $11.1M | ||
| Q2 25 | — | $20.0M | ||
| Q1 25 | — | $10.2M | ||
| Q4 24 | $23.2M | $17.5M | ||
| Q3 24 | $46.4M | $11.3M | ||
| Q2 24 | $8.3M | $8.8M | ||
| Q1 24 | $14.4M | $7.3M |
| Q4 25 | $76.6M | $141.5M | ||
| Q3 25 | $63.4M | $133.6M | ||
| Q2 25 | $9.5M | $139.7M | ||
| Q1 25 | $9.4M | $134.8M | ||
| Q4 24 | $7.1M | $131.4M | ||
| Q3 24 | $7.7M | $125.0M | ||
| Q2 24 | $5.2M | $119.4M | ||
| Q1 24 | $3.7M | $116.3M |
| Q4 25 | $184.9M | $199.2M | ||
| Q3 25 | $165.4M | $202.4M | ||
| Q2 25 | $139.5M | $184.6M | ||
| Q1 25 | $113.5M | $178.1M | ||
| Q4 24 | $96.6M | $177.1M | ||
| Q3 24 | $67.3M | $169.5M | ||
| Q2 24 | $28.9M | $163.9M | ||
| Q1 24 | $26.8M | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $18.4M |
| Free Cash FlowOCF − Capex | $15.8M | $9.7M |
| FCF MarginFCF / Revenue | 25.9% | 12.7% |
| Capex IntensityCapex / Revenue | 0.9% | 11.5% |
| Cash ConversionOCF / Net Profit | 1.34× | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $18.4M | ||
| Q3 25 | $-18.4M | $18.4M | ||
| Q2 25 | $16.3M | $12.3M | ||
| Q1 25 | $20.6M | $2.9M | ||
| Q4 24 | $-21.6M | $15.0M | ||
| Q3 24 | $38.6M | $12.7M | ||
| Q2 24 | $-4.3M | $10.2M | ||
| Q1 24 | $2.6M | $1.2M |
| Q4 25 | $15.8M | $9.7M | ||
| Q3 25 | $-24.9M | $10.7M | ||
| Q2 25 | $5.4M | $4.1M | ||
| Q1 25 | $5.8M | $-12.6M | ||
| Q4 24 | $-28.4M | $3.2M | ||
| Q3 24 | $38.6M | $1.7M | ||
| Q2 24 | $-6.0M | $1.2M | ||
| Q1 24 | $2.6M | $-4.8M |
| Q4 25 | 25.9% | 12.7% | ||
| Q3 25 | -59.3% | 14.9% | ||
| Q2 25 | 12.3% | 6.5% | ||
| Q1 25 | 5.8% | -21.4% | ||
| Q4 24 | -56.7% | 5.2% | ||
| Q3 24 | 55.1% | 3.0% | ||
| Q2 24 | -49.4% | 2.3% | ||
| Q1 24 | 16.4% | -9.5% |
| Q4 25 | 0.9% | 11.5% | ||
| Q3 25 | 15.3% | 10.6% | ||
| Q2 25 | 24.8% | 12.9% | ||
| Q1 25 | 15.0% | 26.2% | ||
| Q4 24 | 13.4% | 19.5% | ||
| Q3 24 | 0.1% | 19.0% | ||
| Q2 24 | 13.8% | 16.3% | ||
| Q1 24 | 0.2% | 11.9% |
| Q4 25 | 1.34× | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | 11.02× | 3.88× | ||
| Q1 25 | 6.93× | 1.09× | ||
| Q4 24 | -11.32× | 3.47× | ||
| Q3 24 | 14.60× | 3.29× | ||
| Q2 24 | -3.09× | 6.94× | ||
| Q1 24 | 176.40× | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TSSI
| Procurement Revenues Segment | $43.2M | 71% |
| System Integration Services Segment | $14.2M | 23% |
| Facilities Segment | $3.5M | 6% |
VMD
Segment breakdown not available.
